Galsky MD, Bajorin DF, Tomita Y, Ye D, et al. Adjuvant nivolumab in muscle-invasive urothelial carcinoma: exploratory biomarker analysis of the randomized phase 3 CheckMate 274 trial. Nat Med 2025;31:3062-3073.
PMID: 40775055